Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.
- Published In:
- International immunopharmacology, 169, 116008 (2026)
- Authors:
- Zahedipour, Fatemeh, Vahdat-Lasemi, Fatemeh, Farhoudi, Leila, Hosseinikhah, Seyedeh Maryam, Amiri, Atefeh, Barati, Mehdi, Sankian, Mojtaba, Zamani, Parvin, Gheybi, Fatemeh, Jamialahmadi, Khadijeh, Jaafari, Mahmoud Reza
- Database ID:
- RPEP-16524
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-16524APA
Zahedipour, Fatemeh; Vahdat-Lasemi, Fatemeh; Farhoudi, Leila; Hosseinikhah, Seyedeh Maryam; Amiri, Atefeh; Barati, Mehdi; Sankian, Mojtaba; Zamani, Parvin; Gheybi, Fatemeh; Jamialahmadi, Khadijeh; Jaafari, Mahmoud Reza. (2026). Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.. International immunopharmacology, 169, 116008. https://doi.org/10.1016/j.intimp.2025.116008
MLA
Zahedipour, Fatemeh, et al. "Combination therapy with VEGFR2 nanoliposomal peptide and paclitaxel in murine models of melanoma: a promising strategy for enhancing the efficacy of cancer immunotherapy.." International immunopharmacology, 2026. https://doi.org/10.1016/j.intimp.2025.116008
RethinkPeptides
RethinkPeptides Research Database. "Combination therapy with VEGFR2 nanoliposomal peptide and pa..." RPEP-16524. Retrieved from https://rethinkpeptides.com/research/zahedipour-2026-combination-therapy-with-vegfr2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.